glp 1 agonist australia Supporting patients through GLP-1 cessation effects Clinical Practice Recommendation On Periprocedural

Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, et al

The beneficial effects of GLP-1 RAs on HRQoL and other outcomes in HFpEF are likely due to pleiotropic impacts, related or not to weight reduction, such as decongestion (mainly due to the reduction of increased plasma volume associated with obesity and epicardial constrain), reverse cardiac remodelling (mainly due to the decrease in epicardial fat and regression of left atrial and LV myopathy, lowering intracardiac pressure) and anti-inflammatory actions, among others

Mol Cell Endocrinol 2001

To view a copy of this licence, visit About this article Cite this article Ard, J., Fitch, A., Fruh, S